Merck KGaA starts M Lab Collaboration Center in Brazil

| By | Life Sciences, Merck KGaA, R&D
0
158

Merck KGaA (known as MSD in USA and Canada officially opened a state-of-the-art M Lab™ Collaboration Center in Brazil. The center will provide Life Science customers with a shared, exploratory environment where they can closely collaborate with Merck scientists and engineers to solve their toughest challenges and accelerate development and production of new therapies.

The lab facility includes non-GMP pilot and bench scale labs for customers to engage in process development support, troubleshooting, demonstrations and hands-on training. It is one of nine such centers around the world, each of which allows pharmaceutical manufacturers to explore new ways to increase productivity, improve processes and mitigate risks.

Each year, more than 1,500 customers visit Merck’s M Lab™ Collaboration Centers, where they work alongside Merck’s team of experts and get access to sizing and simulation tools and methodologies as well as analytical and modeling support. Formal bioprocessing courses are also available, including traditional classroom-style training and interactive, hands-on sessions. Other M Lab™ Collaboration Center locations include China, Singapore, Japan, South Korea, India, France and the United States.

Merck opened its first customer-facing laboratory in 1995 in Massachusetts, USA. The global network has steadily grown over the years, not only to meet the training and process development needs of customers in local regions, but also to allow and ensure successful technology transfer between countries for global customers. In 2015, Merck began reimagining these labs as the M Lab™ Collaboration Centers with a focus on customers.

SOURCE: merck kgaa
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.